12.06.2014 • News

Former Novartis Employee Suspected of Data Manipulation

A former employee of Novartis Pharma KK, the Japan unit of the Swiss drugmaker, has been arrested on suspicion of manipulating data to promote the company's best-selling blood pressure drug Diovan.

Nobuo Shiraishi is suspected of violating Japan's pharmaceutical laws by providing false data to researchers, whose work was intended for use in advertising the drug, the Tokyo District Public Prosecutor's Office said in a statement.

Novartis Pharma KK said it would cooperate with the investigation.

Anyone found guilty of exaggerated advertising of drugs in Japan can be punished with up to two years in prison or a fine of as much as 2 million yen ($19,600), or both.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.